APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quadrivalent Flu Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Quadrivalent Flu Vaccine Industry Growth and Trends Forecast to 2032

20 December 202595 pages

Choose your research edition.

Industry ResearchQuadrivalent Flu Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Quadrivalent Flu Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Quadrivalent Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quadrivalent Flu Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Quadrivalent Flu Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Quadrivalent Flu Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Quadrivalent Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Quadrivalent Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quadrivalent Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Quadrivalent Flu Vaccine include CSL, Sanofi Pasteur, AstraZeneca, GlaxoSmithKline and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Quadrivalent Flu Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Quadrivalent Flu Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Quadrivalent Flu Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Quadrivalent Flu Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Quadrivalent Flu Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Quadrivalent Flu Vaccine Market by Company

CSL

Sanofi Pasteur

AstraZeneca

GlaxoSmithKline

Abbott

Quadrivalent Flu Vaccine Segment by Type

Intramuscular Injection

Nasal Spray

Intradermal Shot

Quadrivalent Flu Vaccine Segment by Application

Clinic

Hospital

Public Health Agency

Other

Quadrivalent Flu Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quadrivalent Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quadrivalent Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quadrivalent Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Quadrivalent Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Quadrivalent Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intramuscular Injection Table 2. Major Company of Nasal Spray Table 3. Major Company of Intradermal Shot Table 4. Global Quadrivalent Flu Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (k doses) Table 6. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Quadrivalent Flu Vaccine Price by Type (2021-2026) & (US$/dose) Table 10. Global Quadrivalent Flu Vaccine Sales by Type (2027-2032) & (k doses) Table 11. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Quadrivalent Flu Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Quadrivalent Flu Vaccine Price by Type (2027-2032) & (US$/dose) Table 15. North America Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (k doses) Table 16. North America Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (k doses) Table 18. Europe Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (k doses) Table 20. Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (k doses) Table 22. Latin America Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (k doses) Table 24. Middle East and Africa Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Quadrivalent Flu Vaccine Industry Trends Table 26. Quadrivalent Flu Vaccine Industry Drivers Table 27. Quadrivalent Flu Vaccine Industry Opportunities and Challenges Table 28. Quadrivalent Flu Vaccine Industry Restraints Table 29. Global Quadrivalent Flu Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Quadrivalent Flu Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Quadrivalent Flu Vaccine Sales by Company (2021-2026) & (k doses) Table 32. Global Quadrivalent Flu Vaccine Sales Share by Company (2021-2026) Table 33. Global Quadrivalent Flu Vaccine Market Price by Company (2021-2026) & (US$/dose) Table 34. Global Quadrivalent Flu Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Quadrivalent Flu Vaccine Major Company Production Sites and Headquarters Table 36. Global Quadrivalent Flu Vaccine Company, Product Type & Application Table 37. Global Quadrivalent Flu Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Quadrivalent Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Quadrivalent Flu Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Quadrivalent Flu Vaccine Sales by Region (2021-2026) & (k doses) Table 42. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Quadrivalent Flu Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Quadrivalent Flu Vaccine Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 46. Global Quadrivalent Flu Vaccine Sales by Region (2027-2032) & (k doses) Table 47. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Quadrivalent Flu Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Quadrivalent Flu Vaccine Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2027-2032) Table 51. Global Quadrivalent Flu Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (k doses) Table 53. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Quadrivalent Flu Vaccine Price by Application (2021-2026) & (US$/dose) Table 57. Global Quadrivalent Flu Vaccine Sales by Application (2027-2032) & (k doses) Table 58. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Quadrivalent Flu Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Quadrivalent Flu Vaccine Price by Application (2027-2032) & (US$/dose) Table 62. North America Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (k doses) Table 63. North America Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (k doses) Table 65. Europe Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (k doses) Table 67. Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (k doses) Table 69. Latin America Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (k doses) Table 71. Middle East and Africa Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. CSL Company Information Table 73. CSL Business Overview Table 74. CSL Quadrivalent Flu Vaccine Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 75. CSL Quadrivalent Flu Vaccine Product Portfolio Table 76. CSL Recent Development Table 77. Sanofi Pasteur Company Information Table 78. Sanofi Pasteur Business Overview Table 79. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 80. Sanofi Pasteur Quadrivalent Flu Vaccine Product Portfolio Table 81. Sanofi Pasteur Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Quadrivalent Flu Vaccine Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 85. AstraZeneca Quadrivalent Flu Vaccine Product Portfolio Table 86. AstraZeneca Recent Development Table 87. GlaxoSmithKline Company Information Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Quadrivalent Flu Vaccine Product Portfolio Table 91. GlaxoSmithKline Recent Development Table 92. Abbott Company Information Table 93. Abbott Business Overview Table 94. Abbott Quadrivalent Flu Vaccine Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 95. Abbott Quadrivalent Flu Vaccine Product Portfolio Table 96. Abbott Recent Development Table 97. North America Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 98. North America Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (k doses) Table 99. North America Quadrivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 100. North America Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032) & (k doses) Table 101. North America Quadrivalent Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 102. North America Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Quadrivalent Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Quadrivalent Flu Vaccine Market Share by Country (2021-2026) Table 105. North America Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Quadrivalent Flu Vaccine Market Share Forecast by Country (2027-2032) Table 107. Europe Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 108. Europe Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (k doses) Table 109. Europe Quadrivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 110. Europe Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032) & (k doses) Table 111. Europe Quadrivalent Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Quadrivalent Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Quadrivalent Flu Vaccine Market Share by Country (2021-2026) Table 115. Europe Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Quadrivalent Flu Vaccine Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (k doses) Table 119. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032) & (k doses) Table 121. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Quadrivalent Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Quadrivalent Flu Vaccine Market Share by Country (2021-2026) Table 125. Asia-Pacific Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Quadrivalent Flu Vaccine Market Share Forecast by Country (2027-2032) Table 127. Latin America Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 128. Latin America Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (k doses) Table 129. Latin America Quadrivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 130. Latin America Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032) & (k doses) Table 131. Latin America Quadrivalent Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Quadrivalent Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Quadrivalent Flu Vaccine Market Share by Country (2021-2026) Table 135. Latin America Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Quadrivalent Flu Vaccine Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (k doses) Table 139. Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032) & (k doses) Table 141. Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Quadrivalent Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Quadrivalent Flu Vaccine Market Share by Country (2021-2026) Table 145. Middle East and Africa Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Quadrivalent Flu Vaccine Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Quadrivalent Flu Vaccine Distributors List Table 150. Quadrivalent Flu Vaccine Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Quadrivalent Flu Vaccine Image Figure 2. Global Quadrivalent Flu Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quadrivalent Flu Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Quadrivalent Flu Vaccine Sales (2021-2032) & (k doses) Figure 5. Intramuscular Injection Image Figure 6. Global Intramuscular Injection Sales YoY Growth (2021-2032) & (k doses) Figure 7. Nasal Spray Image Figure 8. Global Nasal Spray Sales YoY Growth (2021-2032) & (k doses) Figure 9. Intradermal Shot Image Figure 10. Global Intradermal Shot Sales YoY Growth (2021-2032) & (k doses) Figure 11. Global Quadrivalent Flu Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Quadrivalent Flu Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Quadrivalent Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Quadrivalent Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Quadrivalent Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Quadrivalent Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Quadrivalent Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Quadrivalent Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Quadrivalent Flu Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k doses) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k doses) Figure 29. Public Health Agency Image Figure 30. Global Public Health Agency Sales YoY Growth (2021-2032) & (k doses) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k doses) Figure 33. Global Quadrivalent Flu Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Quadrivalent Flu Vaccine Market Share by Application 2025 VS 2032 Figure 35. North America Quadrivalent Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. North America Quadrivalent Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Europe Quadrivalent Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Quadrivalent Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Quadrivalent Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Quadrivalent Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 45. North America Quadrivalent Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 46. North America Quadrivalent Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Quadrivalent Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Quadrivalent Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Quadrivalent Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 50. Europe Quadrivalent Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Quadrivalent Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Quadrivalent Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Quadrivalent Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 54. Asia-Pacific Quadrivalent Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Quadrivalent Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Quadrivalent Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Quadrivalent Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 58. Latin America Quadrivalent Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Quadrivalent Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Quadrivalent Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Quadrivalent Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 62. Middle East and Africa Quadrivalent Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Quadrivalent Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Quadrivalent Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Quadrivalent Flu Vaccine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Quadrivalent Flu Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Nasal Spray
  • Intradermal Shot
Applications
  • Clinic
  • Hospital
  • Public Health Agency
  • Other
Companies covered
  • CSL
  • Sanofi Pasteur
  • AstraZeneca
  • GlaxoSmithKline
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Quadrivalent Flu Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Quadrivalent Flu Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Quadrivalent Flu Vaccine Market by Type
  6. 1.3.1 Intramuscular Injection
  7. 1.3.2 Nasal Spray
  8. 1.3.3 Intradermal Shot
  9. 1.4 Global Quadrivalent Flu Vaccine Market Size by Type
  10. 1.4.1 Global Quadrivalent Flu Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Quadrivalent Flu Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Quadrivalent Flu Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Quadrivalent Flu Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Quadrivalent Flu Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Quadrivalent Flu Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Quadrivalent Flu Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Quadrivalent Flu Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Quadrivalent Flu Vaccine Industry Trends
  2. 2.2 Quadrivalent Flu Vaccine Industry Drivers
  3. 2.3 Quadrivalent Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Quadrivalent Flu Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Quadrivalent Flu Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Quadrivalent Flu Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Quadrivalent Flu Vaccine Price (2021-2026)
  4. 3.4 Global Quadrivalent Flu Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Quadrivalent Flu Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Quadrivalent Flu Vaccine Company, Product Type & Application
  7. 3.7 Global Quadrivalent Flu Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Quadrivalent Flu Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Quadrivalent Flu Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Quadrivalent Flu Vaccine Tier 1, Tier 2, and Tier 3
4 Quadrivalent Flu Vaccine Regional Status and Outlook
  1. 4.1 Global Quadrivalent Flu Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Quadrivalent Flu Vaccine Historic Market Size by Region
  3. 4.2.1 Global Quadrivalent Flu Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Quadrivalent Flu Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Quadrivalent Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Quadrivalent Flu Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Quadrivalent Flu Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Quadrivalent Flu Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Quadrivalent Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Quadrivalent Flu Vaccine by Application
  1. 5.1 Quadrivalent Flu Vaccine Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Public Health Agency
  5. 5.1.4 Other
  6. 5.2 Global Quadrivalent Flu Vaccine Market Size by Application
  7. 5.2.1 Global Quadrivalent Flu Vaccine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Quadrivalent Flu Vaccine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Quadrivalent Flu Vaccine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Quadrivalent Flu Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Quadrivalent Flu Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Quadrivalent Flu Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Quadrivalent Flu Vaccine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Quadrivalent Flu Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL
  2. 6.1.1 CSL Company Information
  3. 6.1.2 CSL Business Overview
  4. 6.1.3 CSL Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Quadrivalent Flu Vaccine Product Portfolio
  6. 6.1.5 CSL Recent Developments
  7. 6.2 Sanofi Pasteur
  8. 6.2.1 Sanofi Pasteur Company Information
  9. 6.2.2 Sanofi Pasteur Business Overview
  10. 6.2.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pasteur Quadrivalent Flu Vaccine Product Portfolio
  12. 6.2.5 Sanofi Pasteur Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Quadrivalent Flu Vaccine Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Quadrivalent Flu Vaccine Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Abbott
  26. 6.5.1 Abbott Company Information
  27. 6.5.2 Abbott Business Overview
  28. 6.5.3 Abbott Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Abbott Quadrivalent Flu Vaccine Product Portfolio
  30. 6.5.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Quadrivalent Flu Vaccine Sales by Country
  2. 7.1.1 North America Quadrivalent Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Quadrivalent Flu Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Quadrivalent Flu Vaccine Market Size by Country
  6. 7.2.1 North America Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Quadrivalent Flu Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Quadrivalent Flu Vaccine Sales by Country
  2. 8.1.1 Europe Quadrivalent Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Quadrivalent Flu Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Quadrivalent Flu Vaccine Market Size by Country
  6. 8.2.1 Europe Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Quadrivalent Flu Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Quadrivalent Flu Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Quadrivalent Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Quadrivalent Flu Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Quadrivalent Flu Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Quadrivalent Flu Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Quadrivalent Flu Vaccine Sales by Country
  2. 10.1.1 South America Quadrivalent Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Quadrivalent Flu Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Quadrivalent Flu Vaccine Market Size by Country
  6. 10.2.1 South America Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Quadrivalent Flu Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Quadrivalent Flu Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Quadrivalent Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Quadrivalent Flu Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Quadrivalent Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Quadrivalent Flu Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Quadrivalent Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Quadrivalent Flu Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Quadrivalent Flu Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Quadrivalent Flu Vaccine Value Chain Analysis
  2. 12.1.1 Quadrivalent Flu Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Quadrivalent Flu Vaccine Production Mode & Process
  7. 12.2 Quadrivalent Flu Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Quadrivalent Flu Vaccine Distributors
  10. 12.2.3 Quadrivalent Flu Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst